Xalatan, Latanoprost News

Objective To evaluate the interaction of intraocular pressure -lowering medications with physiologic day and night changes in aqueous humor dynamics in participants with ocular hypertension.

It is indicated in the treatment of the reduction of elevated intraocular pressure in patients with open angle glaucoma and ocular hypertension.

Pharmaceutical giant Pfizer has hit a legal wall in its bid to block the production of a generic eye drug after the Supreme Court of Canada declined Thursday to hear the company's appeal.

We are pleased to announce the day-one launch of Latanoprost 0.005% w/v Eye Drops solution 2.5ml. It is indicated in the treatment of elevated intraocular pressure in patients with open angle glaucoma and ocular hypertension.